DAFNA Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-83,000	Closed	-$2.14M	–	85
2021 Q1	$2.14M	Buy	+83,000	New	+$2.14M	0.51%	47